Medtronic (MDT) Q1 2013 Earnings Call August 21, 2012 8:00 am ET Executives Jeff Warren Omar S. Ishrak - Chairman and Chief Executive Officer Gary L. Ellis - Chief Financial Officer, Principal Accounting Officer and Senior Vice President Michael J. Coyle - Executive Vice President and Group President of Cardiac & Vascular Group Christopher J. O'Connell - Executive Vice President and Group President of Restorative Therapies Group Analysts Matthew J. Dodds - Citigroup Inc, Research Division Michael N. Weinstein - JP Morgan Chase & Co, Research Division David R. Lewis - Morgan Stanley, Research Division Kristen M. Stewart - Deutsche Bank AG, Research Division Rajeev Jashnani - UBS Investment Bank, Research Division Robert A. Hopkins - BofA Merrill Lynch, Research Division Topher Orr - Goldman Sachs Group Inc., Research Division Bruce M. Nudell - Crédit Suisse AG, Research Division Joshua T. Jennings - Cowen and Company, LLC, Research Division Derrick Sung - Sanford C. Bernstein & Co., LLC., Research Division Joanne K. Wuensch - BMO Capital Markets U.S. PresentationOperator
Good morning. My name is Christie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Medtronic's First Quarter Earnings Release Conference Call. [Operator Instructions] Thank you. It is now my pleasure to hand the program over to Mr. Jeff Warren. Please go ahead. Jeff Warren Thank you, Christie. Good morning, and welcome to Medtronic's First Quarter Conference Call and Webcast. During the next hour, Omar Ishrak, Medtronic Chairman and Chief Executive Officer; and Gary Ellis, Medtronic Chief Financial Officer, will provide comments on the results of our fiscal year 2013 first quarter, which ended July 27, 2012. After our prepared remarks, we will be happy to take your questions.